Inactive Instrument

Annidis Corporation

Equities

RHA.H

CA03589A1003

Advanced Medical Equipment & Technology

Annidis Corporation announced that it has received CAD 0.15 million in funding from YIMAI Technology International Company Limited

November 24, 2015

Annidis Corporation (TSXV:RHA) announced that it has it has issued promissory note for gross proceed of CAD 150,000 to existing investor YIMAI Technology International Company Limited on November 25, 2015. The promissory note carries a coupon of 10% per annum and would mature on November 25, 2016.

Latest news about Annidis Corporation

Annidis Corporation Announces Executive Resignations	26/02/18	CI
Annidis Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017	23/11/17	CI
Annidis Corporation Announces Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2017	25/08/17	CI
Annidis Corporation Announces Audited Consolidated Earnings Results for the First Quarter Ended March 31, 2017	25/05/17	CI
Annidis Corporation Announces Audited Consolidated Earnings Results for the Twelve Months Ended December 31, 2016	28/04/17	CI
Annidis Corporation Announces Executive Changes	24/02/17	CI
Annidis Corporation announced that it expects to receive CAD 2.18 million in funding	29/11/16	CI
Annidis Corporation Announces Private Placement of $500,000 Promissory Note	21/09/16	CI
Annidis Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2016	07/09/16	CI
Annidis Corporation Announces the Resignation of Michael Mueller as Board of Director	07/09/16	CI
Annidis Corporation announced that it has received CAD 0.5 million in funding from Mistarunited Technology Co., Limited	31/08/16	CI
Annidis Corporation Announces Private Placement of $221,000 Promissory Note	08/08/16	CI
Annidis Corporation announced that it has received CAD 0.22 million in funding from Mistarunited Technology Co., Limited	28/07/16	CI
Annidis Corporation Auditor Raises 'Going Concern' Doubt	28/04/16	CI
Annidis Corporation Announces Management Changes	18/04/16	CI
Annidis Corporation announced that it has received CAD 1.3 million in funding from YIMAI Technology International Company Limited	17/04/16	CI
Annidis Corporation announced that it has received CAD 0.1 million in funding from YIMAI Technology International Company Limited	13/04/16	CI
Annidis Corporation announced that it expects to receive CAD 0.1 million in funding from YIMAI Technology International Company Limited	30/03/16	CI
Annidis Corporation announced that it has received CAD 0.15 million in funding from YIMAI Technology International Company Limited	16/03/16	CI
Annidis Corporation announced that it has received CAD 0.87 million in funding from YIMAI Technology International Company Limited	03/03/16	CI
Annidis Corporation Announces Private Placement of $150,000 Promissory Note	22/02/16	CI
Annidis Corporation Announces Management Changes	05/01/16	CI
Annidis Corporation Announces Earnings Results for the Nine Months Ended September 30, 2015	21/12/15	CI
Annidis Corporation announced that it expects to receive funding from YIMAI Technology International Company Limited.	10/12/15	CI
Annidis Corporation announced that it has received CAD 0.15 million in funding from YIMAI Technology International Company Limited	24/11/15	CI

Chart Annidis Corporation

Duration

Period

More charts

Company Profile

Annidis Corporation develops and markets imaging technologies to eye care professionals. The Company has developed a multi-spectral imaging (MSI) system for retinal and choroidal assessment (the RHA). The RHA provides eye-care professionals with a screening tool for early detection and diagnosis of a range of pathologies. The RHA is an ocular pathology management system that integrates MSI with analytic software and management of ocular pathologies, such as glaucoma, age-related macular degeneration and diabetic retinopathy. Its RHA collects and combines multi-spectral information. The RHA is a non-invasive instrument that uses MSI to take pictures of the retinal layers of eye. The images are then processed using the RHA Report software to reveal various layers in the back of the eye. The Company is also engaged in developing RHA Platinum, which is under development with beta units in clinical testing that allows doctors to visualize choroidal and retinal vasculature non-invasively.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.61B

Other Advanced Medical Equipment & Technology